Fernandis Aaron Zefrin, Prasad Anil, Band Hamid, Klösel Roland, Ganju Ramesh Kumar
Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Oncogene. 2004 Jan 8;23(1):157-67. doi: 10.1038/sj.onc.1206910.
The chemokine-CXCL12 and its receptor, CXCR4, have recently been shown to play an important role in regulating the directional migration of breast cancer cells to sites of metastasis. In the present study, we showed that CXCL12 enhanced the chemotaxis, chemoinvasion and adhesive properties of breast cancer cells; parameters that are critical for development of metastasis. We have also evaluated the signaling mechanisms that regulate CXCL12-induced and CXCR4-mediated breast cancer cell motility and invasion. These studies revealed that CXCL12 induces the tyrosine phosphorylation of focal adhesion kinase (FAK) at residues 397 and 577, and of RAFTK/Pyk2 at residues 402 and 579/580. The cytoskeletal proteins paxillin and Crk, as well as tyrosine phosphatase SHP2 and adaptor protein Cbl, were also phosphorylated. CXCL12 induced the activation of PI 3-kinase, and increased its association with Cbl and SHP2. PI 3-kinase, RAFTK/Pyk2 and tyrosine phosphatase inhibitors significantly blocked CXCL12-induced chemotaxis and chemoinvasion. The role of SHP2 and Cbl in CXCL12-induced chemotaxis and chemoinvasion in breast cancer cells was further defined by transiently overexpressing wild-type SHP2, wild-type Cbl, dominant-negative SHP2, Cbl mutants 70Z/3 and G306E or double transfectants of the Cbl and SHP2 constructs. We found a novel role of Cbl in CXCL12-induced chemotaxis, which may be mediated through the activation and formation of a multimeric complex comprised of Cbl, SHP2 and PI 3-kinase. We also observed the activation of matrix metalloproteinases 2 and 9 upon CXCL12 stimulation. These studies provide new information regarding signaling pathways that may regulate CXCL12-induced metastasis in breast cancer cells.
趋化因子CXCL12及其受体CXCR4最近被证明在调节乳腺癌细胞向转移部位的定向迁移中起重要作用。在本研究中,我们发现CXCL12增强了乳腺癌细胞的趋化性、化学侵袭性和黏附特性;这些参数对转移的发生至关重要。我们还评估了调节CXCL12诱导的和CXCR4介导的乳腺癌细胞运动和侵袭的信号传导机制。这些研究表明,CXCL12诱导粘着斑激酶(FAK)在397和577位残基处酪氨酸磷酸化,以及RAFTK/Pyk2在402和579/580位残基处酪氨酸磷酸化。细胞骨架蛋白桩蛋白和Crk,以及酪氨酸磷酸酶SHP2和衔接蛋白Cbl也发生了磷酸化。CXCL12诱导PI 3激酶的激活,并增加其与Cbl和SHP2的结合。PI 3激酶、RAFTK/Pyk2和酪氨酸磷酸酶抑制剂显著阻断CXCL12诱导的趋化性和化学侵袭。通过瞬时过表达野生型SHP2、野生型Cbl、显性负性SHP2、Cbl突变体70Z/3和G306E或Cbl和SHP2构建体的双转染体,进一步明确了SHP2和Cbl在CXCL12诱导的乳腺癌细胞趋化性和化学侵袭中的作用。我们发现Cbl在CXCL12诱导的趋化性中具有新作用,这可能是通过激活并形成由Cbl、SHP2和PI 3激酶组成的多聚体复合物介导的。我们还观察到CXCL12刺激后基质金属蛋白酶2和9的激活。这些研究提供了关于可能调节CXCL12诱导的乳腺癌细胞转移的信号通路的新信息。